Samson Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Samson Pharmaceuticals's estimated annual revenue is currently $5.8M per year.
- Samson Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Samson Pharmaceuticals has 29 Employees.
- Samson Pharmaceuticals grew their employee count by -3% last year.
Samson Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Operations | Reveal Email/Phone |
Samson Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Samson Pharmaceuticals?
Located in the heart of the world best trendsetting city of Los Angeles, Samson Pharmaceuticals Inc. (SPI), is a name you will remember with continuous products deliveries, ones that best serve consumers of health, beauty care and others. SPI is an FDA registered and drug licensed company, currently manufacturing a diverse line of products ranging from OTC, cosmetics, dietary supplements and others.
keywords:N/A
N/A
Total Funding
29
Number of Employees
$5.8M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Samson Pharmaceuticals News
... Honeywell International Inc., Metso Corporation, Rockwell Automation, Samson AG, Schneider Electric, Siemens AG, SKF AB ... Pharmaceuticals Others.
... to hospitals and surgical centers, where the product has been in short supply," said Marvin Samson, Chairman of Avet Pharmaceuticals.
Other Companies in Commerce
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.9M | 29 | -3% | N/A |
#2 | $3.3M | 29 | -6% | N/A |
#3 | N/A | 29 | 4% | N/A |
#4 | $5.5M | 29 | 4% | N/A |
#5 | $5.5M | 30 | 0% | N/A |